14 min listen
Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Nov…
Sergio Giralt, MD, FACP, FASTCT - Charting a New Course in the Treatment Paradigm of Relapsed/Refractory Multiple Myeloma: The Current Snapshot of Nov…
ratings:
Length:
14 minutes
Released:
Apr 21, 2023
Format:
Podcast episode
Description
Please visit answersincme.com/QTQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in multiple myeloma discusses treatment sequencing in relapsed/refractory multiple myeloma (RRMM) and the integration of novel CAR T-cell therapies into the treatment paradigm. Upon completion of this activity, participants should be better able to: Identify the unmet therapeutic needs with current treatments for patients with relapsed/refractory multiple myeloma; Review the significance of the latest clinical data for the use of CAR T cells in pretreated patients with RRMM; and Outline clinical factors that may inform treatment sequencing strategies to optimize outcomes for patients.
Released:
Apr 21, 2023
Format:
Podcast episode
Titles in the series (60)
Kathleen Moore, MD, MS - Targeting Disease Progression in Advanced Ovarian Cancer: Can Combination PARP Inhibitors and Immune Checkpoint Inhibitors Improve Outcomes?: Please visit answersincme.com/AXF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology